bcr1101 BCJ Poster Presentation <p>Large-scale single nucleotide polymorphism analysis of candidates for low-penetrance breast cancer genes</p> Vega A Salas A Phillips C Sobrino B Carracedo B Ruíz-Ponte C Rodríguez-López R Rivas G Benítez J Carracedo A

Fundación Pública Galega de Medicina Xenómica, Hospital Clínico Universitario, Universidad de Santiago de Compostela, Galicia, Spain

Centro Nacional de Xenotipado, Hospital Clínico Universitario, Santiago de Compostela, Galicia, Spain

Unidade de Xenética, Instituto de Medicina Legal, Facultad de Medicina, Universidad de Santiago de Compostela, Galicia, Spain

Departamento de Genética Humana, Centro Nacional Investigaciones Oncológicas, Madrid, Spain

 Breast Cancer Research <p>The Third International Symposium on the Molecular Biology of Breast Cancer</p> Affymetrix, Agilent Technologies, Applied Biosystems, AstraZeneca, Novartis Oncology, Pfizer, Roche Diagnostics (Main Sponsors). Meeting abstracts <p>The Third International Symposium on the Molecular Biology of Breast Cancer</p> Molde, Norway 22–26 June 2005 1465-5411 2005 7 Suppl 2 P1.14 10.1186/bcr1101 17 6 2005

BRCA1 and BRCA2 are high-penetrance genes that account for around 25% of families with hereditary breast cancer 1. Given that no additional high-penetrance susceptibility genes have been found to be involved in breast cancer, it has been proposed that different genetic backgrounds due to the combination of low-penetrance genes (polygenic mechanism) could explain the remaining familial breast cancer risk 2. Hence there is much interest in the search for low-penetrance gene/variants for breast cancer, which exist with high prevalence in the general population.

Single nucleotide polymorphisms (SNPs) have emerged as genetic markers of choice because of their high density and relatively even distribution in the human genomes 34, and are being using for fine mapping of disease loci and for candidate gene association studies. Approximately 10 million SNPs have been identified across the human genome and new technologies are available today for high-throughput genotyping.

In this study we used the SNPlex™ (Applied Biosystems, Foster City, CA, USA) high-throughput genotyping platform, which allows the study of up to 48 SNPs simultaneously, to study 984 SNPs of 92 cancer-related genes, in a total of 480 female cases of breast cancer and 480 female controls.

Gene selection was made on the basis of their involvement in different cancer pathways and genes: DNA reparation, cell cycle control, BRCA1-associated binding proteins, and so on. SNP selection was performed using an indirect approach (1 SNP/10 kb) and based on the individual allele frequency (FAM ≤ 10%) in the European population, using public and private SNP databases and bioinformatics tools (dbSNP, HapMap, Sequenom Real SNP, PUPASNPI Ensembl, and Celera, among others).

To date, 415 SNPs from 44 genes have been genotyped in nine SNPlex pools. A case–control analysis was conducted for the 318 remaining SNPs. Preliminary results showed association in 24 SNPs from 12 candidate genes (P < 0.05). We will present the analysis of the remaining 48 genes at the time of the congress.

Acknowledgments

This work was supported by grants from the Ministerio de Sanidad y Consumo (Fondo de Investigación Sanitaria; Instituto de Salud Carlos III, PI030893; SCO/3425/2002) and Genoma España (CeGen; Centro Nacional de Genotipado; Nodo Santiago de Compostela).

 <p>Genetic heterogeneity and penetrance analysis of the <it>BRCA1 </it>and <it>BRCA2 </it>genes in breast cancer families. Breast Cancer Linkage Consortium</p> Ford D Easton DF Stratton M Narod S Goldgar D Devilee P Bishop DT Weber B Lenoir G Chang-Claude J Am J Hum Genet 1998 62 676 689 10.1086/301749 9497246 <p>Polygenic susceptibility to breast cancer and implications for prevention</p> Pharoah PD Antoniou A Bobrow M Zimmern RL Easton DF Ponder BA Nat Genet 2002 31 33 36 10.1038/ng853 11984562 <p>Prospects for whole-genome linkage disequilibrium mapping of common disease genes</p> Kruglyak L Nat Genet 1999 22 139 144 10.1038/9642 10369254 <p>The sequence of the human genome</p> Venter JC Adams MD Myers EW Li PW Mural RJ Sutton GG Science 2001 291 1304 1351 10.1126/science.1058040 11181995